Vaishali Pharma Profit & Loss Annual

BSE: - | NSE: VAISHALI | ISIN: INE972X01022 | Sector: Biotechnology & Drugs

12.64 +0.83 (7.03%)Updated : 08 Jul 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Operating Expense	99.42	85.56	61.04	69.42
Other Net	3.21	0.38	2.23	1.79
Diluted Weighted Average Shares	2.64	10.62	11.17	10.55
Depreciation/ Amortization	0.49	0.51	0.50	0.46
Operating Income	-0.40	0.72	8.63	6.40
Net Income	0.82	0.72	6.60	4.02
Income Availableto Com Excl Extra Ord	0.82	0.72	6.60	4.02
Net Income Before Taxes	1.23	0.93	8.85	5.73
Other Operating Expenses Total	10.68	0.00	3.77	3.37
Net Income After Taxes	0.82	0.72	6.60	4.02
Income Availableto Com Incl Extra Ord	0.82	0.72	6.60	4.02
Costof Revenue Total	85.67	74.42	54.68	63.50
Gross Profit	13.35	11.86	14.99	12.32
Interest Inc( Exp) Net- Non- Op Total	-1.58	-0.17	-2.01	-2.46
Diluted Net Income	0.82	0.72	6.60	4.02
Provisionfor Income Taxes	0.41	0.21	2.24	1.70
period Type	-	-	-	-
Net Income Before Extra Items	0.82	0.72	6.60	4.02
Total Revenue	99.03	86.28	69.66	75.82
period Length	12.00	12.00	12.00	12.00
Revenue	99.03	86.28	69.66	75.82
Selling/ General/ Admin Expenses Total	2.58	10.64	2.08	2.10
Diluted Normalized EPS	0.31	0.07	0.59	0.38
Diluted EPS Excluding Extra Ord Items	0.31	0.07	0.59	0.38

*All figures in crores except per share values

Trending Stocks

2,224.50+77.50(3.61%)

2,484.60+41.20(1.69%)

343.20+5.55(1.64%)

3,440.60-226.25 (-6.17%)

1,165.40-10.05 (-0.85%)

Related News